Literature DB >> 8866346

The podiatric treatment of hallux abducto valgus and its associated condition, bunion, with Tagetes patula.

M T Khan1.   

Abstract

To assess the effectiveness of marigold therapy using Tagetes patula preparations, a double-blind placebo-controlled trial was designed to be carried out over a period of eight weeks. Sixty patients were entered in the trial. Twenty patients with bilateral hallux abducto valgus and its associated condition, bunion, were randomly selected from 37 subjects for group A. For group B, 40 patients with unilateral hallux abducto valgus and bunion were randomly selected from 69 subjects and subdivided into groups Ba and Bb. Patients with ulcerated conditions, those on medication and those who had undergone surgery for the condition were excluded. The results obtained were highly significant (P < 0.001), suggesting that T. patula preparations, plus protective pad, were effective in reducing the width of the lesion and level of pain of hallux abducto valgus.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8866346     DOI: 10.1111/j.2042-7158.1996.tb03968.x

Source DB:  PubMed          Journal:  J Pharm Pharmacol        ISSN: 0022-3573            Impact factor:   3.765


  3 in total

1.  Effects of Flavonoids from French Marigold (Florets of Tagetes patula L.) on Acute Inflammation Model.

Authors:  Ken Yasukawa; Yoshimasa Kasahara
Journal:  Int J Inflam       Date:  2013-09-22

2.  Constituents of French Marigold (Tagetes patula L.) Flowers Protect Jurkat T-Cells against Oxidative Stress.

Authors:  Irakli Chkhikvishvili; Tamar Sanikidze; Nunu Gogia; Maia Enukidze; Marine Machavariani; Nana Kipiani; Yakov Vinokur; Victor Rodov
Journal:  Oxid Med Cell Longev       Date:  2016-06-28       Impact factor: 6.543

Review 3.  Adjusted Indirect and Mixed Comparisons of Conservative Treatments for Hallux Valgus: A Systematic Review and Network Meta-Analysis.

Authors:  Jianhua Ying; Yining Xu; Bíró István; Feng Ren
Journal:  Int J Environ Res Public Health       Date:  2021-04-06       Impact factor: 3.390

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.